2022 Pharmacotherapy Preparatory Review and Recertification Course -- General Psychiatry, Infectious Diseases I, Infectious Diseases II, and Men's and Women's Health

Sunday, April 24, 2022 from 1:45 PM to 6:00 PM CDT
at Academic and Research Building: First Floor, Room 111
Available for 4.75 hours of CPE credit
Activity Number: 0217-0000-22-014-L01-P

Pharmacotherapy Preparatory Review and Recertification Course is ideal for pharmacy professionals preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination, for Board Certified Pharmacotherapy Specialists (BCPSs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of pharmacotherapy topics.

Developed and presented by board-certified pharmacotherapy specialists, the course provides a comprehensive review of the knowledge domains covered in the pharmacotherapy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Examine pharmacotherapeutic options for managing schizophrenia, major depressive disorder (MDD), bipolar disorder, anxiety and anxiety-like disorders, insomnia, and substance use disorders (SUDs).
2. Select a drug used to treat these disorders on the basis of its unique pharmacologic properties, therapeutic efficacy, adverse effects, and cognitive and behavioral effects.
3. Formulate a pharmacotherapeutic treatment plan for a patient with a diagnosis of schizophrenia, MDD, bipolar disorder, anxiety and anxiety-like disorders, insomnia, or SUD.
4. Identify the presenting signs and symptoms, etiology, and risk factors of respiratory tract infections, urinary tract infections, skin and soft tissue infections, osteomyelitis, central nervous system (CNS) infections, intraabdominal infections, Clostridioides difficile infections, and endocarditis.
5. Recommend appropriate treatment for patients with respiratory tract infections, urinary tract infections, skin and soft tissue infections, osteomyelitis, CNS infections, intra-abdominal infections, C. difficile infections, and endocarditis.
6. Select appropriate preventive therapy for urinary tract infections, CNS infections, endocarditis, and surgical wound infections.
7. Formulate an appropriate regimen to prevent or treat HIV infections, including initiating and monitoring therapy.
8. Discuss appropriate treatment of the various acquired immunodeficiency syndrome opportunistic infections, including primary and secondary prophylaxis.
9. Describe appropriate treatment and preventive therapy for tuberculosis, including infections with drug-resistant organisms.
10. Design appropriate therapeutic regimens for treating systemic and superficial fungal infections and classify the various antifungal agents.
11. Recommend appropriate treatment options for patients with menopausal symptoms and osteoporosis.
12. Identify drugs that are considered safe and unsafe during pregnancy and lactation, and differentiate between information resources for pregnancy and lactation.
13. Select the appropriate treatment for infertility or sexual dysfunction on the basis of patient-specific factors.
14. Devise a pharmacotherapeutic plan for appropriate contraceptive use, including assessment of estrogen and progestin-related adverse effects or drug interactions, contraceptive method mishaps, and use of emergency contraception.
15. Identify common menstrual disorders and sexually transmitted diseases and recommend appropriate pharmacotherapy.

General Psychiatry 1:45 PM to 2:45 PM Speakers Speaker: Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice, The Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida View Biography Cauffield

Infectious Diseases I 2:45 PM to 3:45 PM Speakers Speaker: Curtis L. Smith, Pharm.D., FCCP, BCPS Professor Ferris State University, College of Pharmacy Clinical Pharmacist Sparrow Health System Lansing, Michigan View Biography Smith

Infectious Diseases II 3:55 PM to 4:45 PM Speakers Speaker: Curtis L. Smith, Pharm.D., FCCP, BCPS Professor Ferris State University, College of Pharmacy Clinical Pharmacist Sparrow Health System Lansing, Michigan View Biography Smith

Men's and Women's Health 4:45 PM to 6:00 PM Speakers Speaker: Ashley H. Meredith, Pharm.D., MPH, FCCP, BCACP, BCPS, CDE Clinical Associate Professor, Purdue University College of Pharmacy Clinical Pharmacy Specialist, Primary Care, Eskenazi Health Indianapolis, Indiana View Biography Meredith